Rare Variant Studies in 500,000 UK Biobank Participants

Physicians, fellows, residents, physician assistants, nurse practitioners, nurses, and other healthcare professionals need to receive regular updates on professional guidelines, advances in basic science and clinical research, and emerging treatment modalities and management strategies for patients with endocrine disorders. The series will explore new models of multidisciplinary care in the field, especially as it relates to patients with cardiometabolic diseases such as obesity and diabetes. The series aims to expand the knowledge of learners, promote adherence to evidence-based guidelines, enhance the quality of endocrinology care, disseminate best clinical practices, and improve patient outcomes.

Target Audience

Physicians, fellows, residents, nurses, and other healthcare professionals.

Learning Objectives

At the conclusion of the session, the participants should be able to:

  • Describe the role of rare variation in human metabolic disorders.

  • Review the central role of human genetics in drug discovery.

  • Outline the general approach for large whole-exome sequencing-based case-control studies.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
Course expires: 

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or register to take this course.